Ranbaxy effect: Indian government defends pharma industry
Few isolated cases cannot undermine well regulated system, says commerce ministry
Sun-Ranbaxy merger: CCI says deal may hurt competition, seeks public opinion
The merger would lead to creation of the world's fifth-largest maker of generic drugs
Sun Pharma, Novartis settle lawsuit over Glivec
Sun Pharma allowed to launch generic version of anti-leukamia drug next year
Maharashtra bans anti-tick medication temporarily
26 heads of cattle killed after being administered injection in Parbhani district
Pharma lobby obtains stay on Centre’s drug price control order
Drug manufacturers also trying to scuttle government’s drug pricing policy
A patent triumph of public interest
New flexibilities make public interest safeguards integral to drug patent rights
Three pharma units under scanner for exposing workers to polyacrylate hazard
Gujarat High court directs medical check-up of all employees
Government withdraws NPPA’s power to fix prices of non-essential medicines
Prices of cardiac, diabetes, HIV/AIDS drugs likely to be affected
Indian company gets licence to manufacture and sell patented cancer drug
This is the first-ever compulsory licence given to a generic drug company
Budget 2023-24 live: Greening the economy is among top 7 priorities, says Nirmala Sitharaman in budget speech
Live updates from the budget speech February 1, 2023